The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2015

Filed:

Dec. 27, 2013
Applicant:

Bayer Intellectual Property Gmbh, Monheim, DE;

Inventors:

Thomas Langguth, Jena, DE;

Stefan Bracht, Jena, DE;

Michael Dittgen, Apolda, DE;

Petra Huber, Munich, DE;

Dirk Schenk, Dietramszell, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 13/00 (2006.01); A61K 9/70 (2006.01); A61F 13/02 (2006.01); A61L 15/16 (2006.01); A61K 47/32 (2006.01); A61K 31/56 (2006.01); A61K 31/567 (2006.01); A61K 31/57 (2006.01);
U.S. Cl.
CPC ...
A61K 47/32 (2013.01); A61K 9/7053 (2013.01); A61K 9/7061 (2013.01); A61K 9/7076 (2013.01); A61K 31/56 (2013.01); A61K 9/70 (2013.01); A61K 31/567 (2013.01); A61K 31/57 (2013.01);
Abstract

The present invention relates to a patch comprising a drug-containing layer with low content of hormones, such as gestodene, and optionally an estrogen (e.g. ethinyl estradiol). Upon administering the patch to a woman, plasma levels of at least 1.0 ng/ml of Gestodene is achieved at steady state conditions without the need of incorporating penetration enhancers or permeation enhancers in the drug-containing layer. Satisfactorily plasma levels of the hormones is also achieved throughout a period of at least 1 week, making the patch applicable for being used in female contraception with the concept of administering the patch ones weekly.


Find Patent Forward Citations

Loading…